EverSource Wealth Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
4,146
+1,145
+38% +$78.1K 0.01% 761
2026
Q1
$194K Buy
3,001
+48
+2% +$3.38K 0.01% 1075
2025
Q4
$199K Sell
2,953
-96
-3% -$6.46K 0.01% 951
2025
Q3
$224K Buy
3,049
+364
+14% +$24.2K 0.01% 850
2025
Q2
$140K Buy
2,685
+174
+7% +$9.9K 0.01% 1033
2025
Q1
$160K Buy
2,511
+211
+9% +$12.3K 0.01% 746
2024
Q4
$110K Buy
2,300
+30
+1% +$1.54K 0.01% 872
2024
Q3
$130K Sell
2,270
-111
-5% -$6.36K 0.01% 706
2024
Q2
$132K Buy
2,381
+41
+2% +$1.8K 0.01% 704
2024
Q1
$89.2K Sell
2,340
-67
-3% -$2.51K 0.01% 751
2023
Q4
$89K Sell
2,407
-82
-3% -$3.09K 0.01% 681
2023
Q3
$95.1K Buy
2,489
+40
+2% +$1.64K 0.01% 581
2023
Q2
$88.3K Buy
+2,449
New +$83.6K 0.01% 622
2022
Q2
– Sell
-215
Closed -$9K – 1779
2022
Q1
$9K Hold
215
– – ﹤0.01% 1013
2021
Q4
$9K Buy
+215
New +$8.03K ﹤0.01% 998

Other funds holding HALO

EverSource Wealth Advisors's HALO Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Halozyme (HALO) stake by 38% in Q2 2026, buying an estimated $78.1K and bringing the position to 4,146 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #761.

EverSource Wealth Advisors first reported a position in HALO in Q4 2021 and has held it in 15 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • EverSource Wealth Advisors held 4,146 shares of Halozyme worth $325K as of Q2 2026.
  • EverSource Wealth Advisors bought 1,145 Halozyme shares in Q2 2026, an estimated $78.1K.
  • Halozyme made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #761 holding.
  • EverSource Wealth Advisors first reported a position in Halozyme in Q4 2021 and has held it in 15 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.